The Laboratory Diagnosis of Prostatic Adenocarcinoma

References

• Dixon F. J., Moore R. A. Tumors of the male sex organs, Atlas of Tumor Pathology, sec. 8 fasc. 31b and 32, Armed Forces Inst. Pathol. Department of Defense, Washington, DC 1952
   Google Scholar
• Ashley D. J. B. Histological Appearance of Tumors, 3rd ed. Churchill Livingstone, New York 1978; Vol. 2: 783
   Google Scholar
• Gleason D. F. Classification of prostatic carcinomas. Cancer Chemother. Rep. 1966; 50: 125
   PubMedGoogle Scholar
• Blennerhasset J. B., Vickery A. L. Carcinoma of the prostate gland: and anatomical study of tumor location. Cancer 1966; 19: 980
   PubMed Web of Science ®Google Scholar
• Rotkin I. D. Risk varieables associated with prostatic cancer: Preliminary studies. 1980; Vol. 2: 2289–2299, Prevention and Detection of Cancer, Part II, Detection, International Symposium 3
   Google Scholar
• Ross R. K., Deapen D. M., Casagrande J. T., Paganini-Hill A., Henderson B. E. A cohort study of mortality from cancer of the prostate in Catholic priests. Br. J. Cancer 1981; 43: 233
   Google Scholar
• Cancer statistics. Ca 1982; 32: 15, 1982
   Google Scholar
• Franks L. M. Latent carcinoma of the prostate. J. Pathol. Bacteriol. 1954; 68: 603
   PubMedGoogle Scholar
• Whitmore W. F., Jr. Hormone therapy in prostatic cancer. Am. J. Med. 1956; 21: 697
   PubMedGoogle Scholar
• Gutman E. B., Sproul E. E., Gutman A. B. Significance of increased phosphatase activity of bone at the site of osteoplastic metastases secondary to carcinoma of the prostate gland. Am. J. Cancer 1936; 28: 485
   Google Scholar
• Gutman A. B., Gutman E. B. An “acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J. Biol. Chem. 1938; 136: 201
   Google Scholar
• Huggins C., Hodges C. V. Studies on prostatic cancer: the effect of castration on estrogen or androgen injection on serum phosphatases in metastatic cancer of the prostate. Cancer Res. 1941; 1: 293
   Google Scholar
• Lam K. W., Li C. Y., Yam L. T., Smith R. S., Hacker B. Comparison of prostatic and non-prostatic acid phosphatase. Prostatic Acid Phosphatase Measurement: Its Role in Detection and Management of Prostatic Cancer, L. M. Shaw, W. A. Romas, H. Cohen. N.Y. Academy of Science, New York 1982; 1
   Google Scholar
• Lam K. W., Yam L. T., Wilbur H. J., Taft E., Li C. Y. Comparison of acid phosphatase isoenzymes of human seminal fluid prostate and leukocytes. Clin. Chem. 1979; 25: 1285
   PubMedGoogle Scholar
• Nadji M., Morales A. R. Immunochemistry of prostatic acid phosphatase. Prostatic Acid Phosphatase Measurement: Its Role in Detection and Management of Prostatic Cancer, L. M. Shaw, W. A. Romas, H. Cohen. N.Y. Academy of Science, New
   Google Scholar
• Roy A. V., Bowen M. E., Hayden J. E. Sodium thymolphthalein monophosphate: A new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin. Chem. 1971; 17: 1093
   PubMed Web of Science ®Google Scholar
• Bowers G. N., Jr. Acid phosphatase measurement in the clinical lab. Prostatic Acid Phosphatase Measurement: Its Role in Detection and Management of Prostatic Cancer, L. M. Shaw, W. A. Romas, H. Cohen. N.Y. Academy of Science, New York 1982; 73
   Google Scholar
• Shulman S., Mamrod L., Gonder M., Soanes W. A. The detection of prostatic acid phosphatase by antibody reactions in gel diffusion. J. Immunol. 1964; 93: 474
   PubMed Web of Science ®Google Scholar
• Cooper J. F., Foti A. G. A radioimmunoassay for prostatic acid phosphatase: Methodology and range of normal male serum values. Invest. Urol. 1974; 12: 98
   Google Scholar
• Foti A. G., Herschman H., Cooper J. F. A solid phase radioimmunoassay for human prostatic acid phosphatase. Cancer Res. 1975; 35: 2446
   Google Scholar
• Foti A. G., Herschman H., Cooper J. F. Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and radioimmunoassay. Clin. Chem. 1977; 23: 95
   PubMed Web of Science ®Google Scholar
• Foti A. G., Cooper J. F., Herschman H., Malvaez R. R. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. N. Engl. J. Med. 1977; 297: 1357
   PubMed Web of Science ®Google Scholar
• Ablin R. J. Immunological studies of normal benign and malignant human prostatic tissue. Cancer 1972; 29: 1570
   Google Scholar
• Ablin R. J., Bhatti R. A. Tumor-associated immunity in prostatic cancer. Cancer Prevention, R. J. Ablin. Marcel Dekker, Inc., New York 1979; Vol. 2: 719
   Google Scholar
• Ablin R. J., Bronson P., Soanes W. A., Witebsky E. Tissue and species-specific antigens of normal human prostatic tissue. J. Immunol. 1970; 104: 13290
   Google Scholar
• Foti A. G., Herschman H., Cooper J. F. Isoenzymes of acid phosphatase in normal and cancerous human prostatic tissue. Cancer Res. 1977; 37: 4120
   PubMedGoogle Scholar
• Van Etten R. L., Saini M. S. Selective purification of tartrate inhibitable acid phosphatases. Rapid and efficient purification (to homogeneity) of human and canine acid phosphatases. Clin. Chem. 1978; 24: 1525
   PubMed Web of Science ®Google Scholar
• Vihko P., Sajanti E., Janne O., Peltonen L., Vihko R. Serum prostate specific acid phosphatase: Development and validation of a specific radioimmunoassay. Clin. Chem. 1978; 24: 1915
   PubMedGoogle Scholar
• Vihko P., Kostama A., Jane O., Sajanti E., Vihko R. Rapid radioimmunoassay of prostate-specific acid phosphatase in human serum. Clin. Chem. 1980; 26: 1544
   PubMed Web of Science ®Google Scholar
• Choe B. D., Pontes E. J., Morrison M. K., Rose N. R. Human prostatic acid phosphatases: A double antibody radioimmunoassay. Arch. Androl. 1978; 1: 227
   Web of Science ®Google Scholar
• Josephson L., Houle P. Stability of prostatic acid phosphatase in normal human serum. Clin. Chem. 1980; 26: 1631
   Google Scholar
• Grenner G., Schmidtberger R. Enzyimmunologische bestimmung der sauren prostataphophatase. J. Clin. Chem. Clin. Biochem. 1980; 26: 433
   Google Scholar
• Cooper E. H., Glashan R., Robinson M. R. G., Morgan D. B., Trautner K. The evaluation of a new enzyme immunoassay for the measurement of prostatic acid phosphatase. Clin. Chem. Acta 1981; 113: 27
   Google Scholar
• Griffiths J., Rippe D. F., Panfili P. R. Comparison of enzyme-linked immuno absorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease. Clin. Chem. 1982; 28: 183
   PubMed Web of Science ®Google Scholar
• Davies S. N., Griffiths J. Prostate-specific acid phosphatases: Further studies with immunological techniques. Clin. Chim. Acta 1982; 122: 29
   Google Scholar
• Chu T. M., Wang M. C., Scott W. W., Gibbons R. P., Johnson D. E., Schmidt J. D., Loening S. A., Rout G. R., Murphy G. P. Immunochemical detection of serum prostatic acid phosphatase. Invest. Urol. 1978; 15: 319
   PubMedGoogle Scholar
• Killian C. S., Vargas F. P., Lee C. L., Wang M. C., Murphy G. P., Chu T. M. Quantitative counter immunoelectrophoresis assay for prostatic acid phosphatase. Invest. Urol. 1980; 18: 219
   PubMedGoogle Scholar
• Mahan D. E., Doctor B. P. A radioimmunoassay for human prostatic acid phosphatase levels in prostatic disease. Clin. Biochem. 1979; 12: 10
   PubMed Web of Science ®Google Scholar
• Griffiths J. Prostate specific acid phosphatase: Re-evaluation of radioimmunoassay in diagnosing prostatic disease. Clin. Chem. 1980; 26: 433
   PubMed Web of Science ®Google Scholar
• Lindholm G. R., Stirtan M. S., Liedtke R. J., Batjer J. D. Prostatic acid phosphatase by radioimmunoassay: Sensitivity compared with enzymatic assay. J. Am. Med. Assoc. 1980; 244: 2071
   Google Scholar
• Dass S., Bowen N. L., Bagshawe K. D. Rapid fully automated radioimmunoassay of prostatic acid phosphatase in human serum. Clin. Chem. 1980; 26: 1583
   Google Scholar
• Quinones G. R., Rohner T. J., Drago J. R., Demers L. M. Will prostatic acid phosphatase determination by radioimmunoassay increase the early diagnosis of early prostatic cancer. J. Urol. 1981; 125: 361
   PubMed Web of Science ®Google Scholar
• Brody J. P., Savory J., Sturgill B. C., Lehman M. R., Wills M. R. Prostatic acid phosphatase as measured by two radioimmunoassay kits in the detection of prostatic adenocarcinoma. Clin. Chem. 1981; 27: 605
   Google Scholar
• Henderson A. R., Nealon D. A. Enzyme measurements by mass: An interim review of the clinical efficacy of some mass measurements of prostatic acid phosphatase and the isoenzymes of creatine kinase. Clin. Chim. Acta 1981; 115: 9
   PubMedGoogle Scholar
• Davies S. N., Gochman N. Evaluation of a monoclonal antibody-based immunoradiometric assay for prostatic acid phosphatase
   Google Scholar
• Lee C. L., Wang M. C., Murphy G. P., Chu T. M. A solid phase fluorescent immunoassay for human prostatic acid phosphatase. Cancer Res. 1978; 38: 2871
   PubMed Web of Science ®Google Scholar
• Lee C. L., Chu T. M., Wajsman L. Z., Slack N. H., Murphy G. P. Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer. Urology 1980; 15: 338
   PubMed Web of Science ®Google Scholar
• Griffiths J. Clinical applications of fluorimmunoassay: An evaluation in the diagnosis of early prostate cancer. Proc. 11th Int. Cong. Clinical Chemistry. De Gruyt, New York 1982; 1241
   Google Scholar
• Wajsman Z., Chu T. M., Saroff J., Slack N., Murphy G. P. Two new direct and specific methods of acid phosphatase determination. Urology 1979; 13: 8
   PubMed Web of Science ®Google Scholar
• Killian C. S., Vargas F. P., Lee C. L., Wang M. S., Murphy G. P., Chu T. M. Quantitative counterimmunoelectrophoresis assay for prostatic acid phosphatase. Invest. Urol. 1980; 18: 219
   PubMedGoogle Scholar
• Wright G. L., Schellhammer P. F., Brassil D. N., Sieg S. M., Lefell M. S. Comparison of counter current immunoelectrophoretic assay with commercial radioimmunoassay for measuring prostatic acid phosphatase. Clin. Chem. 1981; 27: 1747
   Google Scholar
• Gupta M. K., Rajaraman S., Gupta S. K., Hewitt C. B., Deodhar S. D. Immunochemical measurement of serum prostatic acid phosphatase (PAP): Clinical evaluation of radioimmunoassay and counter immunoelectrophoresis. J.A.C.P. 1981; 76: 430
   Google Scholar
• Green F. T., Thompson I. M. The effects of various manipulations on serum phosphatase levels in benign disease. J. Urol. 1974; 112: 232
   Google Scholar
• Belville W. D., Mahan D. E., Clements J. C., McLeod D. G. Prostatic trauma and release of acid phosphatase—Radioimmunochemical and enzymatic comparison. Urology 1980; 16: 168
   PubMed Web of Science ®Google Scholar
• Brenckman W. D., Lastinger B. B., Sedor F. Unpredictable fluctations in serum acid phosphatase activity in prostatic cancer. J. Am. Med. Assoc. 1981; 245: 2501
   Google Scholar
• Shaw L. M., Yang N., Neal M., Croop W. Immunological and clinical specificity of the immunochemical determination of prostatic acid phosphatase. Prostatic Acid Phosphatase Measurement: Its Role in Detection and Management of Prostatic Cancer, L. M. Shaw, W. A. Romas, H. Cohen. N.Y. Academy of Science, New York 1982; 73
   Google Scholar
• Bruce A. W., Mahan E. D. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate. Prostatic Acid Phosphatase Measurement: Its Role in Detection and Management of Prostatic Cancer, L. M. Shaw, W. A. Romas, H. Cohen. N.Y. Academy of Science, New York 1982; 133
   Google Scholar
• Feld R. D., Witte D. L. Presence of creatine kinase BB isoenzyme in some patients with prostatic cancer. Clin. Chem. 1977; 28: 1930
   Google Scholar
• Forman D. T. The significance of creatine kinase (CK BB) in metastatic cancer of the prostate. Ann. Clin. Lab. Sci. 1979; 9: 333
   PubMed Web of Science ®Google Scholar
• Hoag G. N., Amies D. R., Colquhoun B. D. P. The production of creatine kinase isoenzyme BB in the sera of a patient with prostatic carcinoma and in tumor homogenates. Clin. Biochem. 1978; 11: 38
   PubMed Web of Science ®Google Scholar
• Aleyassine H., Mac Isaac S. G. The diagnostic significance of serum creatine kinase BB isoenzyme in adenocarcinoma of the prostate. Clin. Biochem. 1980; 13: 109
   PubMed Web of Science ®Google Scholar
• Griffiths J. C. Cells, organelles and enzymes: Studies in neoplastic pathophysiology. Progress in Clinical Enzymology, D. M. Goldberg, M. Werner. Masson Publ., New York 1980; 4
   Google Scholar
• Griffiths J. C. The continued evaluation of tumor markers—the value of creatine kinase 1(BB) isoenzyme. Curr. Flow 1980; 3: 1
   Google Scholar
• Thompson R. J., Graham J. G., McQueen I. N. F., Kynoch P. A. M., Brown K. W. Radioimmunoassay of brain type creatine kinase BB isoenzyme in human tissues and in serum of patients with neurological disorders. J. Neurol. Sci. 1980; 47: 241
   PubMed Web of Science ®Google Scholar
• Feld R. D., Van Steirteghem A. C., Zweig M. H., Weimar G. W., Narayana A. S., Witte D. L. The presence of creatine kinase BB isoenzyme in patients with prostatic cancer. Clin. Chim. Acta 1980; 100: 267
   PubMed Web of Science ®Google Scholar
• Thompson R. J., Rubery E. D., Jones H. M. Radioimmunoassay of serum creatine kinase BB as a tumor marker for breast cancer. Lancet 1980; 2: 673
   PubMed Web of Science ®Google Scholar
• Oliver J. A., Elhilale M. M., Beletsky P., McKinnon K. J. LD isoenzymes in benign and malignant prostate tissue: The LD 5/1 ratio as an index of malignancy. Cancer 1970; 25: 863
   PubMed Web of Science ®Google Scholar
• Hein R. C., Grayhack J. T., Goldberg E. Prostatic fluid lactic dehydrogenase isoenzyme patterns of prostatic cancer and hyperplasia. J. Urol. 1975; 113: 511
   Google Scholar
• Guinan P., Gilham N., Nagubadi F., Bush T. R. What is the best test to detect prostate cancer. Ca 1982; 31(3)141
   Google Scholar
• Albert Z., Orlowski J., Orlowski M., Szewczuk A. Histochemical and biochemical investigations of gamma glutamyl transferase in the tissues of man and laboratory rodents. Acta Histochem. 1964; 18: 78
   PubMed Web of Science ®Google Scholar
• Rosalki S. B., Rowe J. A. Gamma glutamyl transferase activity in human seminal fluid. Lancet 1973; 1: 323
   PubMed Web of Science ®Google Scholar
• Chu T. M., Wang M. C., Kuciel R., Valenzuela L., Murphy G. P. Enzyme markers in human prostatic cancer. Cancer Treat. Rep. 1977; 61: 193
   Google Scholar
• Wang M. C., Valenzuela L. A., Murphy G. P., Chu T. M. Purification of a human prostate specific antigen. Invest. Urol. 1979; 17(2)159
   PubMedGoogle Scholar
• Papsidero L. D., Wang M. C., Valenzuela L. A., Murphy G. P., Chu T. M. A prostate antigen in sera of prostatic cancer patients. Cancer Res. 1980; 40: 2428
   PubMed Web of Science ®Google Scholar
• Papsidero L. D., Kuriyama M., Wang M. C., Horoszewicz J., Leong S. S., Valenzuela L. A., Murphy G. P., Chu T. M. Prostate antigen: A marker for human prostate epithelial cells. J. Natl. Cancer Inst. 1981; 66(1)37
   Google Scholar
• Reynoso G., Chu T. M., Guinan P. Carcino-embryonic antigen in patients with tumors of the urogenital tract. Cancer 1972; 31: 1
   Google Scholar
• LoGerfo P., Krupey J., Hansen H. J. Demonstration of an antigen common to several varieties of neoplasia. N. Engl. J. Med. 1971; 285: 138
   PubMed Web of Science ®Google Scholar
• Kiesling V. J., Watson R. A. A closer look at serum prostatic acid phosphatase as screening test. Urology 1980; 16: 242
   Google Scholar
• Watson R. A., Tang D. G. The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer. N. Engl. J. Med. 1980; 303: 497
   PubMed Web of Science ®Google Scholar